EA201590778A1 - ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC) - Google Patents

ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)

Info

Publication number
EA201590778A1
EA201590778A1 EA201590778A EA201590778A EA201590778A1 EA 201590778 A1 EA201590778 A1 EA 201590778A1 EA 201590778 A EA201590778 A EA 201590778A EA 201590778 A EA201590778 A EA 201590778A EA 201590778 A1 EA201590778 A1 EA 201590778A1
Authority
EA
Eurasian Patent Office
Prior art keywords
galactocerebrozide
galaktosidase
man
cleaning
combined
Prior art date
Application number
EA201590778A
Other languages
English (en)
Other versions
EA032680B1 (ru
Inventor
Йенс Фог
Клаэс Андерссон
Пиа Хюден
Пиа Рингхольм Гульстад
Керстин Лунделль
Магнус Эртман
Original Assignee
Эйс Байосайенсиз А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйс Байосайенсиз А/С filed Critical Эйс Байосайенсиз А/С
Publication of EA201590778A1 publication Critical patent/EA201590778A1/ru
Publication of EA032680B1 publication Critical patent/EA032680B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/287—Non-polar phases; Reversed phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/288—Polar phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01046—Galactosylceramidase (3.2.1.46)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/52—Sorbents specially adapted for preparative chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к способу очистки рекомбинантной галактоцереброзид-β-галактозидазы человека (rhGALC) из клеточной культуры, при котором фракцию указанной клеточной культуры, содержащей rhGALC, подвергают хроматографии на трех различных смолах.
EA201590778A 2012-11-13 2013-11-13 ОЧИСТКА РЕКОМБИНАНТНОЙ ГАЛАКТОЦЕРЕБРОЗИД-БЕТА-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC) EA032680B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201270699 2012-11-13
PCT/DK2013/050378 WO2014075688A1 (en) 2012-11-13 2013-11-13 PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE β-GALACTOSIDASE (rhGALC)

Publications (2)

Publication Number Publication Date
EA201590778A1 true EA201590778A1 (ru) 2016-01-29
EA032680B1 EA032680B1 (ru) 2019-07-31

Family

ID=54209221

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590778A EA032680B1 (ru) 2012-11-13 2013-11-13 ОЧИСТКА РЕКОМБИНАНТНОЙ ГАЛАКТОЦЕРЕБРОЗИД-БЕТА-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)

Country Status (16)

Country Link
US (1) US20150284698A1 (ru)
EP (1) EP2920198B1 (ru)
JP (1) JP6035427B2 (ru)
KR (1) KR101783466B1 (ru)
CN (1) CN104854122B (ru)
AU (1) AU2013347260B2 (ru)
BR (1) BR112015010796B1 (ru)
CA (1) CA2890358C (ru)
EA (1) EA032680B1 (ru)
ES (1) ES2751369T3 (ru)
HK (1) HK1213915A1 (ru)
IL (1) IL238775B (ru)
NZ (1) NZ707753A (ru)
PL (1) PL2920198T3 (ru)
WO (1) WO2014075688A1 (ru)
ZA (1) ZA201502738B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105777862A (zh) * 2012-10-24 2016-07-20 建新公司 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子
CN108176386B (zh) * 2018-01-16 2020-11-06 武汉轻工大学 一种三聚氰胺键合色谱固定相及其制备方法和金属离子改性三聚氰胺键合色谱固定相
CN113101909B (zh) * 2021-05-11 2023-07-18 博格隆(浙江)生物技术有限公司 一种层析介质及其制备方法
EP4234695A1 (en) * 2022-02-24 2023-08-30 Sartorius BIA Separations d.o.o. Methods for the selective removal of contaminants during a process of purifying biologic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2628746T3 (en) * 2006-04-04 2019-04-01 Chiesi Farm Spa A method for the concentration of a polypeptide
CN101410408A (zh) * 2006-04-04 2009-04-15 希尔制药爱尔兰有限责任公司 用于浓缩多肽的方法
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CA3112632A1 (en) * 2008-01-18 2009-07-23 Biomarin Pharmaceutical Inc. Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
CN101597614A (zh) * 2008-11-24 2009-12-09 中国农业科学院生物技术研究所 编码β-半乳糖苷酶的基因及其表达和应用
US20110318324A1 (en) * 2010-06-25 2011-12-29 Shire Human Genetic Therapies, Inc. Methods and compositions for cns delivery of b-galactocerebrosidase

Also Published As

Publication number Publication date
AU2013347260B2 (en) 2016-07-28
CA2890358A1 (en) 2014-05-22
IL238775B (en) 2019-02-28
CN104854122A (zh) 2015-08-19
BR112015010796A2 (ru) 2017-08-22
JP6035427B2 (ja) 2016-11-30
EP2920198B1 (en) 2019-09-25
BR112015010796B1 (pt) 2022-08-02
NZ707753A (en) 2019-07-26
ZA201502738B (en) 2019-09-25
EP2920198A1 (en) 2015-09-23
EA032680B1 (ru) 2019-07-31
IL238775A0 (en) 2015-06-30
US20150284698A1 (en) 2015-10-08
KR101783466B1 (ko) 2017-10-10
HK1213915A1 (zh) 2016-07-15
KR20150117638A (ko) 2015-10-20
WO2014075688A1 (en) 2014-05-22
PL2920198T3 (pl) 2020-03-31
CA2890358C (en) 2020-02-11
AU2013347260A1 (en) 2015-05-21
ES2751369T3 (es) 2020-03-31
CN104854122B (zh) 2021-10-08
JP2015535422A (ja) 2015-12-14

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
HRP20181357T1 (hr) Novi postupci pročišćavanja proteina
DK2691411T3 (da) Buffersystem til proteinoprensning
IN2014DN08481A (ru)
CO6940433A2 (es) Compuestos inhibidores de metaloenzimas
DK3339442T3 (da) Fremgangsmåder til forøgelse af den cellulolyseforbedrende aktivitet af et polypeptid
UA110813C2 (uk) Лікування ліподистрофії
DK2904088T3 (da) Gas-tilført fermentationssystem
BR112014001120A2 (pt) métodos de separação de polipeptídeos
SG10201606218WA (en) Purified Proteins
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
UY34483A (es) Polipeptido
MX368474B (es) Uso de benralizumab para mejorar síntomas de asma.
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
EA201590778A1 (ru) ОЧИСТКА КОМБИНИРОВАННОЙ ГАЛАКТОЦЕРЕБРОЗИД-β-ГАЛАКТОЗИДАЗЫ ЧЕЛОВЕКА (rhGALC)
UY34312A (es) Compuesto de benzotiazolona
EA201491034A1 (ru) Экспрессионная кассета
DK2809343T3 (da) Fremgangsmåde til fermentering
EA201391772A1 (ru) Способ диагностики ревматоидного артрита
MX2015010006A (es) Purificacion de proteinas mejorada a traves de una etapa de desglicosilacion.
EA201500210A1 (ru) Способ переэтерификации эфиров ретинола
IN2014DN07923A (ru)
CO7141428A2 (es) Proceso para la elaboración de undecapéptidos cíclicos
IL237978A0 (en) A high safety process for the preparation of purified fractions of stem cells
IL227409A0 (en) Purification of an alpha 1 protease inhibitor obtained from cell culture

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM